RECRUITING

Vascular Effects of High-Salt After Preeclampsia

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Women who develop preeclampsia during pregnancy are more likely to develop and die of cardiovascular disease later in life, even if they are otherwise healthy. Importantly, women who had preeclampsia have an exaggerated vascular responsiveness to hypertensive stimuli, such as high-salt intake, compared to women who had a healthy pregnancy. The reason why this occurs is unclear but may be related to impaired endothelial function and dysregulation of the angiotensin system that occurs during the preeclamptic pregnancy and persists postpartum, despite the remission of clinical symptoms. While the association between a history of preeclampsia and vascular dysfunction leading to elevated CVD risk is well known, the mechanisms underlying this dysfunction remains unclear. The purpose of this study is to examine the role of vascular mineralocorticoid receptor, the terminal receptor in the angiotensin system that contributes to blood pressure regulation, in mediating exaggerated microvascular endothelial dysfunction before and after a high-salt stimulus. This will help us better understand the mechanisms of microvascular dysfunction these women, and how inhibition of these receptors may improve microvascular function. In this study, we use the blood vessels in the skin as a representative vascular bed for examining mechanisms of microvascular dysfunction in humans. Using a minimally invasive technique (intradermal microdialysis for the local delivery of pharmaceutical agents) we examine the blood vessels in a nickel-sized area of the skin.

Official Title

Role of the Mineralocorticoid Receptor in Microvascular Endothelial Dysfunction After Preeclampsia

Quick Facts

Study Start:2024-12-15
Study Completion:2027-11-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06749418

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * women who had preeclampsia and women who did not have preeclampsia
  2. * 12 weeks to 5 years postpartum
  3. * 18-45 years old
  1. * history of hypertension or metabolic disease before pregnancy
  2. * history of gestational diabetes
  3. * history of gestational hypertension without preeclampsia
  4. * skin diseases
  5. * current tobacco use
  6. * current antihypertensive medication
  7. * statin or other cholesterol-lowering medication
  8. * currently pregnant
  9. * body mass index less than 18.5 kg/m2
  10. * allergy to materials used during the experiment.(e.g. latex),
  11. * known allergy to study drugs or salt-supplement

Contacts and Locations

Study Contact

Kelsey Schwartz, PhD
CONTACT
319-467-1732
kelsey-schwartz@uiowa.edu

Principal Investigator

Anna Reid-Stanhewicz, PhD
PRINCIPAL_INVESTIGATOR
University of Iowa

Study Locations (Sites)

University of Iowa
Iowa City, Iowa, 52242
United States

Collaborators and Investigators

Sponsor: Anna Stanhewicz, PhD

  • Anna Reid-Stanhewicz, PhD, PRINCIPAL_INVESTIGATOR, University of Iowa

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-15
Study Completion Date2027-11-15

Study Record Updates

Study Start Date2024-12-15
Study Completion Date2027-11-15

Terms related to this study

Additional Relevant MeSH Terms

  • Preeclampsia
  • Preeclampsia Postpartum